Austrianni GmbH is a new biotechnology company founded in 2015 to develop novel antibody-based therapeutics for the prevention and treatment of tuberculosis and other important infectious diseases.
Austrianni GmbH
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.austrianni.com
Founded2015
Disease Focus
Development Stage
STOCK CODENon Listed
AddressCampus Vienna Biocenter 51030ViennaAustria
Campus Vienna Biocenter 51030
Vienna
Austria
Contact Number+43 1 22 600 75
+43 1 22 600 75
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]